Hope Therapeutics Expands Mental Health Network with Dr. Rebecca Cohen & Cohen Associates
Healthcare investors and mental health advocates: Hope Therapeutics and Interventional Psychiatry Network (owned by NRx Pharmaceuticals) have acquired a strategic interest in Cohen & Associates, LLC, further expanding their clinical reach and capabilities.
📌 Key Highlights:
Dr. Rebecca Cohen appointed Medical Director at Hope Therapeutics
Focused on depression, PTSD, and mood disorders
Incorporation of Cohen & Associates into the Hope Network
Expertise in Transcranial Magnetic Stimulation (TMS) treatment
Mission: expand access to life-changing mental health therapies for millions of Americans
This partnership strengthens Hope Therapeutics’ leadership in advanced interventional psychiatry and mental health innovation.
🔖 YouTube Tags:
#HopeTherapeutics #NRxPharmaceuticals #MentalHealth #DepressionTreatment #PTSD #InterventionalPsychiatry #TMS #DrRebeccaCohen #CohenAssociates #Psychopharmacology #HealthcareInnovation #SuicidePrevention #NewsOut #JaneKing
